FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for amiodarone hydrochloride (generic antiarrhythmic) filed by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• AMIODARONE HYDROCHLORIDE (Amiodarone hydrochloride)

Snippet

SUPPL AP for AMIODARONE HYDROCHLORIDE (AMIODARONE HYDROCHLORIDE)